STAT November 6, 2025
John Wilkerson

Experts said Medicare drug price negotiations may have played a role in Thursday’s announcement

The Trump administration’s deal on weight loss drugs might have been made possible in part by Biden’s Medicare drug price negotiation program, three experts said.

Trump’s deal will offer lower prices for weight loss drugs to Medicare and Medicaid users, along with patients paying out of pocket. Many of the program’s details were not included in the White House announcement, and big questions...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma / Biotech
Related Articles:
What’s new with GLP-1s
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable

Share Article